Tamoxifen induces changes in the lipid composition of the retinal pigment epithelium cell line D407

Pharmacology and Toxicology

Volumn 91, Issue 1, 2002, Pages 13-21

  Engelke, Maria ^a   Tykhonova, Svitlana ^a   Zorn Kruppa, Michaela ^a   Diehl, Horst ^a  

^a UNIVERSITY OF BREMEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE; PROTEIN KINASE C; TAMOXIFEN; ANTIESTROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; FATTY ACID; LIPOSOME; PHOSPHOLIPID;

ARTICLE; BREAST CANCER; CELL CYCLE; CELL MEMBRANE FLUIDITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; LIPID BILAYER; LIPID COMPOSITION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA ROD; RETINOPATHY; SECOND MESSENGER; CELL DIVISION; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; MEMBRANE FLUIDITY; RETINA ROD OUTER SEGMENT;

ANTINEOPLASTIC AGENTS, HORMONAL; CELL DIVISION; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; ESTROGEN ANTAGONISTS; FATTY ACIDS; FLOW CYTOMETRY; HUMAN; LIPIDS; LIPOSOMES; MEMBRANE FLUIDITY; PHOSPHOLIPIDS; PIGMENT EPITHELIUM OF EYE; ROD OUTER SEGMENTS; SUPPORT, NON-U.S. GOV'T; TAMOXIFEN; HUMANS;

EID: 0036020055     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2002.910103.x     Document Type: Article

References (47)

1. Lipids of plasma, retina, and retinal pigment epithelium in Swedish Briard dogs with a slowly progressive retinal dystrophy
2. Protein kinase C, calcium and phospholipid degradiation
3. Tamoxifen-model membrane interactions: An FTIR study
4. A cytopathogenic, apoptosis-inducing variant of hepatitis A virus
5. Isolation of plasma membranes from the bovine retinal pigment epithelium
6. Induction of transforming growth factor β1 in human breast cancer in vivo following tamoxifen treatment
7. Tamoxifen activates cellular phospholipase C and D and elicits protein kinase C translocation
8. Retinopathy associated with low-dose tamoxifen
9. 8-isomerase and other lanosterol-converting enzymes by tamoxifen
10. Interactions of Laurdan with phosphatidylcholine liposomes: A high pressure FTIR study
11. Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells
12. A reliable and rapid procedure to estimate drug partitioning in biomembranes
13. The anticancer drug tamoxifen induces changes in the physical properties of model and native membranes
14. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture
15. Effect of stradial and tamoxifen on brain membranes: Investigation by infrared and fluorescence spectroscopy
16. Successive isolation and separation of the major lipid fractions including gangliosides from single biological samples
17. Defective phagocytosis of isolated rod outer segments by RCS rat retinal pigment epithelium in culture
18. Tamoxifen perturbs lipid bilayer order and permeability. Comparison of DSC, fluorescence anisotropy, Laurdan generalized polarization and carboxyfluorescein leakage studies
19. Microenzymatic fluorescence assay for serum cholesterol
20. Tamoxifen retinopathy at low dosage
21. ROS ingestion by RPE cells is turned off by increased protein kinase C activity and by increased calcium
22. Rationally designed analogues of tamoxifen with improved calmodulin antagonism
23. Effect of tamoxifen on cholesterol synthesis in HepG2 cells and cultured rat hepatocytes
24. A combined assay of cell viability and in vitro cytotoxicity with a highly water soluble tetrazolium salt, neutral red and crystal violet
25. Antiestrogen action in breast cancer cells: Modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites
26. Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment
27. Lipid composition changes induced by tamoxifen in a bacterial model system
28. The phagocytosis of rod outer segments is inhibited by selected drugs in retinal pigment epithelial cell cultures
29. Evaluation of the cytotoxicity of selected systemic drugs and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cells
30. Quantification of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence
31. Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients
32. A simplification of the protein assay method of Lowry et al. which is more generally applicable
33. Fluorescence spectroscopy in the study of membrane fluidity: Model membrane systems
34. Tamoxifen increases membrane fluidity at high concentrations
35. Transforming growth factor-beta regulates human retinal pigment epithel cell phagocytosis by influencing a protein kinase C-dependent pathway
36. Fluidity parameters of lipid regions determined by fluorescence polarization
37. Involvement of calcium in retinal pigment epithelium cell proliferation and pigmentation
38. Modulation of the enzymatic activities in isolated lymphocyte plasma membranes by enzymatic modification of phospholipid fatty acids
39. Effects of tamoxifen, toremifen and chloroquine on the lysosomal enzymes in cultured retinal pigment epithelial cells
40. alpha-Fetoprotein-mediated transfer of arachidonic acid into cultured cloned cells derived from rat rhabdomycosarcoma
41. Effects of pharmacological modulation of intracellular signaling systems on retinal pigment epithelial cell attachment to extracellular matrix proteins
42. A universal reagent for phospholipid analysis
43. Altered membrane fatty acids of cultured human retinal pigment epithelium persistently infected with rubella virus may affect secondary cellular function
44. Retinopathy caused by treatment with tamoxifen in low dosage
45. Tamoxifen and related compounds decrease membrane fluidity in liposomes. Mechanism for the antioxidant action of tamoxifen and relevance to its anticancer and cardioprotective actions?
46. Tamoxifen: New membrane mediated mechanisms of action and therapeutic advances
47. Participation of the retinal pigment epithelium in the rod outer segment renewal process